Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: George T. Santamaria who wrote (3428)	12/26/1997 2:56:00 PM
From: David S.	Respond to of 6136

I agree wholeheartedly

To: George T. Santamaria who wrote (3428)	12/26/1997 3:33:00 PM
From: Izzy	Read Replies (4) \| Respond to of 6136

George, you can always take the lead. Which of the following do you want us to talk about: 1) flat AGPH stock price, 2) clinical HIV/AIDS therapy, 3) experimental AIDS treatment, 4) AGPH drug pipeline, 5) "acute retroviral syndrome" [HIV] characterized by fever, joint pain, and night sweats, 6) viral core p24 antigen (produced by actively replicating HIV) testing to diagnose newly acquired HIV infection, 7) status of HIV vaccines, 8) pure AGPH related info only, or 9) whatever? You can start the discussion going in whichever direction you want to go.